Source: Pharmacy Times articles
The meaningful results were reported in the DESTINY-Breast09 trial.
Read More
Recent Content
- Unseen Threats: The Hospital Environment’s Role in C difficile Colonization
- Aspiring to Make a Difference for Immigrants
- Oral Colchicine Receives FDA Orphan Drug Designation for Pericarditis
- Raising Awareness for Adolescents and Young Adults with Cancer
- Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers
- Analysis Reveals Polypharmacy Challenges in Patients With Cancer
- Trastuzumab Deruxtecan Plus Pertuzumab Improves Progression-Free Survival in Patients With HER2+ Metastatic Breast Cancer
- Enhertu Combo Improves Progression in HER2+ Metastatic Breast Cancer
- My 11-Year Metastatic Breast Cancer Story Defied the Standard Path
- A Step Forward: Optimizing the Delivery of Pegaspargase Therapy in Adult Patients With ALL